ANDA 80914, held by Watson Labs. Rauwolfia Serpentina Root.
As of Nov 15, 2026, ANDA 80914 (Rauwolfia Serpentina), held by Watson Labs, was first approved by FDA on Feb 15, 1973, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 15, 1973 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Rauwolfia Serpentina100MG ยท tablet;oral | Rauwolfia Serpentina Root | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
